Results

• All
• Video
• Audio
• Images

• Most recent

1–6 of 6 results for Dennis M. Marcus

• 

  Expert Panel: Faricimab and Aflibercept 8 mg in Diabetic Retinopathy

  Judy E. Kim, MD, FASRS

  Chirag D. Jhaveri, MD, FASRS

  Michael S. Ip, MD

  Arshad M. Khanani, MD, MA, FASRS

  Jordana G Fein, MD, MS

  Dennis M. Marcus, MD

  Diana V Do, MD, FASRS

  Annual Meeting Talks

  2024

• 

  Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of DR Worsening Over Time: Results of DRCR Retina Network Protocol AA

  Dennis M. Marcus, MD

  Annual Meeting Talks

  2022

• 

  Suprachoroidal Delivery of RGX-314 for Diabetic Retinopathy Without CI-DME: Early Results From the Phase II ALTITUDE Study

  Dennis M. Marcus, MD

  Annual Meeting Talks

  2021

• 

  Complications, Compliance, and 2-Year Outcomes After Endolaserless Vitrectomy With Aflibercept Monotherapy for PDR-Related Vitreous Hemorrhage

  Dennis M. Marcus, MD

  Annual Meeting Talks

  2020

• 

  Widefield Fluorescein Angiographic-Guided Aflibercept (WFFAGA) Monotherapy for Proliferative Diabetic Retinopathy (PDR)

  Dennis M. Marcus, MD

  Annual Meeting Talks

  2019

• 

  Endolaserless Vitrectomy with Intravitreal Aflibercept

  Dennis M. Marcus, MD

  Updates from the Field

  2017